blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1948608

EP1948608 - PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  18.01.2013
Database last updated on 12.07.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU
published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
MILLENNIUM PHARMACEUTICALS, INC.
40 Landsdowne Street
Cambridge, MA 02139 / US
[2008/31]
Inventor(s)01 / GRANT, Craig
10 Burgley Rise
Burwell CB5 0LW / GB
02 / KANTER, James P.
9591 Alcosta Blvd.
San Ramon, CA 94583 / US
03 / LANGLANDS, Graeme
44 Northfield Park
Soham, Cambs CB7 5UZ / GB
 [2008/31]
Representative(s)Sexton, Jane Helen
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2012/11]Sexton, Jane Helen
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Former [2008/31]Sexton, Jane Helen
J.A. Kemp & Co. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date06837238.207.11.2006
[2008/31]
WO2006US43635
Priority number, dateUS20050735224P08.11.2005         Original published format: US 735224 P
[2008/31]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2007056517
Date:18.05.2007
Language:EN
[2007/20]
Type: A2 Application without search report 
No.:EP1948608
Date:30.07.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 18.05.2007 takes the place of the publication of the European patent application.
[2008/31]
Type: B1 Patent specification 
No.:EP1948608
Date:14.03.2012
Language:EN
[2012/11]
Search report(s)International search report - published on:EP17.04.2008
ClassificationIPC:C07D213/75
[2008/31]
CPC:
A61K31/44 (EP,KR,US); A61K31/194 (EP,US); A61K31/616 (EP,US);
A61K9/20 (US); A61P11/00 (EP); A61P43/00 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D213/75 (EP,KR,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/31]
TitleGerman:PHARMAZEUTISCHE SALZE UND POLYMORPHE AUS N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMID, EINEM FAKTOR-XA-HEMMER[2008/31]
English:PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR[2008/31]
French:SELS PHARMACEUTIQUES ET POLYMORPHES DU N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE, UN INHIBITEUR DU FACTEUR X[2008/31]
Entry into regional phase31.03.2008National basic fee paid 
31.03.2008Designation fee(s) paid 
31.03.2008Examination fee paid 
Examination procedure31.03.2008Examination requested  [2008/31]
28.12.2010Despatch of a communication from the examining division (Time limit: M04)
05.05.2011Reply to a communication from the examining division
08.06.2011Communication of intention to grant the patent
14.10.2011Fee for grant paid
14.10.2011Fee for publishing/printing paid
Divisional application(s)EP11187927.6  / EP2431358
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  28.12.2010
Opposition(s)17.12.2012No opposition filed within time limit [2013/08]
Fees paidRenewal fee
17.11.2008Renewal fee patent year 03
24.11.2009Renewal fee patent year 04
23.11.2010Renewal fee patent year 05
23.11.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.11.2006
CY14.03.2012
CZ14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
BG14.06.2012
IS14.07.2012
LU07.11.2012
[2014/34]
Former [2014/27]CY14.03.2012
CZ14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
BG14.06.2012
IS14.07.2012
LU07.11.2012
Former [2013/33]CY14.03.2012
CZ14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
BG14.06.2012
IS14.07.2012
Former [2012/50]CY14.03.2012
CZ14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
SK14.03.2012
IS14.07.2012
Former [2012/49]CY14.03.2012
CZ14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
PL14.03.2012
RO14.03.2012
SI14.03.2012
IS14.07.2012
Former [2012/48]CY14.03.2012
EE14.03.2012
LT14.03.2012
LV14.03.2012
Former [2012/41]CY14.03.2012
LT14.03.2012
LV14.03.2012
Former [2012/39]LT14.03.2012
LV14.03.2012
Former [2012/33]LT14.03.2012
Cited inInternational search[DX]US6376515  (ZHU BING-YAN [US], et al) [DX] 1-28 * the whole document * * example 206 ** example 261 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.